AN2 Therapeutics Inc ANTX Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
AN2 Therapeutics Inc (ANTX)
AN2 Therapeutics Inc (ANTX) Financials

AN2 Therapeutics Inc (ANTX)

1.37

-0.02

(-1.44%)

At close: November 27 3:00PM

Delayed by 15 minutes

1.40

0.03

( 2.19% )

After Hours: 3:33PM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	0	0	0	0	0	0	0
Operating Income	-11.77M	-12.48M	-16.04M	-16.6M	-18.18M	-18.82M	-18.3M	-15.88M
Pre Tax Income	-11.34M	-11.84M	-15.32M	-15.8M	-16.71M	-16.9M	-16.62M	-14.44M
Net Income	-11.34M	-11.84M	-15.32M	-15.8M	-16.71M	-16.9M	-16.62M	-14.44M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	-11.81M	-12.47M	-15.32M	-15.8M	-16.71M	-16.9M	-16.62M	-14.44M
EBITDA	-11.77M	-12.48M	-16.04M	-16.6M	-18.18M	-18.82M	-18.3M	-15.88M

Year End December 30 2023	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	0	0
Operating Income	-21.57M	-42.26M	-69.64M
Pre Tax Income	-21.54M	-40.96M	-64.73M
Net Income	-28.06M	-42.78M	-64.73M
Preferred Dividends	-6.52M	-1.82M	0
Basic Earnings Per Share (EPS)	-0.005	-2.205	-2.177
EBIT	-21.61M	-42.31M	-64.73M
EBITDA	-21.57M	-42.26M	-69.64M

AN2 Therapeutics

Colombier Acquisition

Ftse Italia Small Cap

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions